Tomita, Y.
270  Ergebnisse:
Personensuche X
?
1

Generation and assessment of cytokine-induced killer cells ..:

Li, C.M.Y ; Tomita, Y ; Dhakal, B...
http://purl.org/au-research/grants/nhmrc/1156391.  , 2024
 
?
2

Nivolumab plus cabozantinib versus sunitinib for first-line..:

Powles, T ; Burotto, M ; Escudier, B...
Powles , T , Burotto , M , Escudier , B , Apolo , A B , Bourlon , M T , Shah , A Y , Suárez , C , Porta , C , Barrios , C H , Richardet , M , Gurney , H , Kessler , E R , Tomita , Y , Bedke , J , George , S , Scheffold , C , Wang , P , Fedorov , V , Motzer , R J & Choueiri , T K 2024 , ' Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma : extended follow-up from the phase III randomised CheckMate 9ER trial ' , ESMO Open , vol. 9 , no. 5 , 102994 , pp. 1-11 . https://doi.org/10.1016/j.esmoop.2024.102994.  , 2024
 
?
3

Clinical application of cytokine-induced killer (CIK) cell ..:

Man Ying Li, C ; Li, R ; Drew, P...
Cancer Treatment Reviews, 2024; 122:102665-1-102665-11.  , 2024
 
?
 
?
7

Cross-Sectional Relationship Between Atrial Conduction Dela..:

Ueda A ; Kasagi S ; Maeno K...
https://www.dovepress.com/cross-sectional-relationship-between-atrial-conduction-delay-and-arter-peer-reviewed-fulltext-article-VHRM.  , 2023
 
?
 
?
10

Ethnic comparison in takotsubo syndrome. novel insights fro..:

Imori Y ; Kato K ; Cammann VL...
info:eu-repo/semantics/altIdentifier/pmid/34013386.  , 2022
 
?
11

Adjuvant atezolizumab versus placebo for patients with rena..:

Pal S. K ; Uzzo R ; Karam J. A...
info:eu-repo/semantics/altIdentifier/pmid/36099926.  , 2022
 
?
12

A phylogenetic analysis of two Preludes from J. S. Bach's W..:

Windram, H. F ; Charlston, T ; Tomita, Y.
https://researchonline.rcm.ac.uk/id/eprint/2093/1/Windram%20et%20al.%20AAM.pdf.  , 2022
 
?
14

In vitro synergistic inhibition of HT-29 proliferation and ..:

Tomita, Y ; Smith, E ; Palethorpe, H.M...
http://purl.org/au-research/grants/arc/DP160104641.  , 2021
 
?
15

Expert consensus on perioperative immunotherapy for local a..:

Qiu, B ; Cai, K.C ; Chen, C...
Qiu , B , Cai , K C , Chen , C , Chen , J , Chen , K N , Chen , Q X , Cheng , C , Dai , T Y , Fan , J Q , Fan , Z H , Hu , J , Hu , W D , Huang , Y C , Jiang , G N , Jiang , J , Jiang , T , Jiao , W J , Li , H C , Li , Q , Liao , Y D , Liu , H X , Liu , J F , Liu , L X , Liu , Y , Long , H , Luo , Q Q , Ma , H T , Mao , N Q , Pan , X J , Tan , F W , Tan , L J , Tian , H , Wang , D , Wang , W X , Wei , L , Wu , N , Wu , Q C , Xiang , J Q , Xu , S D , Yang , L , Zhang , H , Zhang , L J , Zhang , P , Zhang , Y , Zhang , Z F , Zhu , K S , Zhu , Y M , Um , S W , Oh , I J , Tomita , Y , De Ruysscher , D , Vanneste , B L & Gao , S 2021 , ' Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer ' , Translational Lung Cancer Research , vol. 10 , no. 9 , pp. 3713-3736 . https://doi.org/10.21037/tlcr-21-634.  , 2021
 
1-15